Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We evaluated whether serum bilirubin levels can predict the development of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM). Methods: This was a retrospective observational longitudinal study of patients presenting at the Pusan National University Hospital. A total of 349 patients with T2DM and preserved kidney function (estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2) were enrolled. The main outcome was the development of CKD stage 3 or greater. The patients were divided into four groups according to the quartiles of the total serum bilirubin levels at baseline. Results: The group with the lowest range of total serum bilirubin level (Q1) showed the highest cumulative incidence of CKD stage 3 or greater than that of the other lower quartiles (Q1 vs. Q4; hazard ratio [HR], 6.75; 95% confidence interval [CI], 1.54 to 29.47; p = 0.011). In multivariate analysis, the risk of developing CKD stage 3 or greater was higher in the second lowest quartile of the serum bilirubin level than that in the highest quartile of the serum bilirubin level (Q2 vs. Q4; HR, 9.36; 95% CI, 1.33 to 65.73; p = 0.024). In the normoalbuminuria subgroup (n = 236), multivariate analysis showed that the risk of developing CKD stage 3 or greater was higher in the lowest quartile of the serum bilirubin level than that in the highest quartile of the serum bilirubin level (Q1 vs. Q4; HR, 7.36; 95% CI, 1.24 to 35.82; p = 0.019). Conclusions: Serum bilirubin might be an early clinical marker for predicting the progression of CKD in patients with T2DM and preserved renal function.
Abstract
Background/Aims: We evaluated whether serum bilirubin levels can predict the development of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM). Methods: This was a retrospective observational longitudinal study of patients presenting at the Pusan National University Hospital. A total of 349 patients with T2DM and preserved kidney function (estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2) were enrolled. The main outcome was the development of CKD stage 3 or greater. The patients were divided into four groups according to the quartiles of the total serum bilirubin levels at baseline. Results: The group with the lowest range of total serum bilirubin level (Q1) showed the highest cumulative incidence of CKD stage 3 or greater than that of the other lower quartiles (Q1 vs. Q4; hazard ratio [HR], 6.75; 95% confidence interval [CI], 1.54 to 29.47; p = 0.011). In multivariate analysis, the risk of developing CKD stage 3 or greater was higher in the second lowest quartile of the serum bilirubin level than that in the highest quartile of the serum bilirubin level (Q2 vs. Q4; HR, 9.36; 95% CI, 1.33 to 65.73; p = 0.024). In the normoalbuminuria subgroup (n = 236), multivariate analysis showed that the risk of developing CKD stage 3 or greater was higher in the lowest quartile of the serum bilirubin level than that in the highest quartile of the serum bilirubin level (Q1 vs. Q4; HR, 7.36; 95% CI, 1.24 to 35.82; p = 0.019). Conclusions: Serum bilirubin might be an early clinical marker for predicting the progression of CKD in patients with T2DM and preserved renal function.
참고문헌 (24)
- 안재희, "Prevalence and Determinants of Diabetic Nephropathy in Korea: Korea National Health and Nutrition Examination Survey", Diabetes and Metabolism Journal, 38(2), pp.109~119 (2014), 대한당뇨병학회[DOI]
- American Diabetes Association, "(9) Microvascular complications and foot care", Diabetes Care, 38(Suppl), pp.S58~S66 (2015)
- Kim WJ, "High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function", J Diabetes Complications, 28, pp.130~134 (2014)
- Giacco F, "Oxidative stress and diabetic complications", Circ Res, 107, pp.1058~1070 (2010)
- Arias IM., "The excretion of conjugated bilirubin by the liver cell", Medicine (Baltimore), 45, pp.513~515 (1966)
- Stocker R, "Bilirubin is an antioxidant of possible physiological importance", Science, 235, pp.1043~1046 (1987)
- Inoguchi T, "Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes", JAMA, 298, pp.1398~1400 (2007)
- Fukui M, "Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes", Kidney Int, 74, pp.1197~1201 (2008)
- Zelle DM, "Support for a protective effect of bilirubin on diabetic nephropathy in humans", Kidney Int, 79, pp.686~ (2011)
- Stevens LA, "Assessing kidney function: measured and estimated glomerular filtration rate", N Engl J Med, 354, pp.2473~2483 (2006)
- Molitch ME, "Diabetic nephropathy", Diabetes Care, 26(Suppl 1), pp.S94~S98 (2003)
- Madsen-Bouterse SA, "Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives", Rev Endocr Metab Disord, 9, pp.315~327 (2008)
- Fujii M, "Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase", Kidney Int, 78, pp.905~919 (2010)
- Baynes JW., "Role of oxidative stress in development of complications in diabetes", Diabetes, 40, pp.405~412 (1991)
- Sonta T, "In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker", Biochem Biophys Res Commun, 330, pp.415~422 (2005)
- Shuji Sasaki, "The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications", Diabetes and Metabolism Journal, 36(4), pp.255~261 (2012), 대한당뇨병학회[DOI]
- Riphagen IJ, "Bilirubin and protection against progression of diabetic nephropathy", Proceedings of the Kidney Week 2012: American Society of Nephrology 45th Annual Meeting (2012)
- Brenner BM, "Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy", N Engl J Med, 345, pp.861~869 (2001)
- Lewis EJ, "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes", N Engl J Med, 345, pp.851~860 (2001)
- Toya K, "Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus", J Diabetes Investig, 5, pp.228~235 (2014)
- ), "Diabetes Care", 2014, 252~258
- Mazzone GL, "Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules", Biochem Biophys Res Commun, 386, pp.338~344 (2009)
- Hirata K, "Increased expression of selectins in kidneys of patients with diabetic nephropathy", Diabetologia, 41, pp.185~192 (1998)
- Okada S, "Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes", Diabetes, 52, pp.2586~2593 (2003)